1 year return (CAGR)
-71.05%
Celyad SA Exchange (NASDAQ, USD)
CYAD
-
-0.03 (-5.42%)
HealthcareBiotechnology & Medical Research
Loading...
3 year return (CAGR)
-63.22%
5 year return (CAGR)
-55.35%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
11.84M
Price/Sales
-
Ent value
-331.74K
Price/Book
0.61
Div yield
-
Growth years
-
Div growth
-
FCF payout
-
Trailing P/E
80.00
PEG
-
Forward P/E
-
EPS growth
-20.92%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 0.52 |
| Daily high | 0.52 |
| Daily low | 0.52 |
| Daily Volume | 0K |
| 1y analyst estimate | 8.52 |
| Beta | 1.69 |
| EPS (TTM) | 81.77 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| CYAD | S&P500 | |
| Current price drop from All-time high | -99.18% | -5.34% |
| Highest price drop | -99.77% | -56.47% |
| Date of highest drop | 23 May 2023 | 9 Mar 2009 |
| Avg drop from high | -68.39% | -10.68% |
| Avg time to new high | 329 days | 12 days |
| Max time to new high | 1450 days | 1805 days |
News
No items found